The Federal Trade Commission on Tuesday ramped up the pressure on prescription-drug middlemen who influence the accessibility and affordability of medications.
Prescription-drug middlemen face more pressure from FTC in new report
Read Next
- ‘Dirty 15’ countries targeted for ‘reciprocal’ duties
- FBI searches homes of Indiana University professor
- Newsmax stock starts trading on NYSE
- AMC bets on premium screens as Hollywood slate boasts blockbusters
- United Microelectronics shares pop on GlobalFoundries deal report
- XTB’s Head of Risk Management Andrzej Przybylsk to step down
- Takes on rivals OpenAI, Anthropic
